In this series, experts discuss best practices for clinical use of onabotulinumtoxinA in the managements of overactive bladder.
EP. 1: Optimizing onabotA for OAB: What are some common misconceptions?
“Like any disease state, you want to make sure you have the right diagnosis; otherwise, you're not going to have a successful treatment plan," says Karyn S. Eilber, MD.
EP. 2: Karyn S. Eilber, MD, on patient counseling for onabotA treatment for OAB
The use of onabotulinumtoxinA (onabotA, Botox) for the treatment of overactive bladder comes with several important considerations.
EP. 3: Administering onabotA: Improving patient comfort and easing anxiety
An expert walks through specific actions that urologists and their teams can take before, during, and after the procedure.
EP. 4: Considerations for patient follow-up after onabotA administration
An expert details key post-procedural recommendations following onabotulinumtoxinA injection for OAB.
Zanzalintinib plus nivolumab shows promising clinical activity in ccRCC
Adding niraparib to AAP extends rPFS in HRR-positive mCSPC
ARANOTE: Darolutamide improves HRQoL in mHSPC
COMRADE: Olaparib plus radium-223 improves rPFS in mCRPC